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INTRODUCTION
Multidrug resistant (MDR) Gram-negative 
bacteria have resistance to many antimicrobial 
compounds by multiple mechanisms including 
reduced outer membrane permeability, and 
active efflux mechanisms by efflux pumps. 
Efflux pumps in pathogenic bacteria and 
their roles in excreting entered antimicrobial 
agents to outer vicinity of the cell is one of 
several mechanisms that lead to bacterial drug 
resistances.
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ABSTRACT 
Background and aims: Some medicinal plants particularly those with antimicrobial 
properties contain compounds that potentiate the activity of antimicrobials against 
pathogenic bacteria. This study was planned to search the antibacterial activities of the 
hydro alcoholic and chloroform extracts of Berberis vulgaris L. root and their synergistic 
effects with ciprofloxacin against some gram-negative pathogenic bacteria. 
Methods: After grinding, powder of Berberis vulgaris L. roots were extracted with 
ethanol 85% and chloroform by maceration method. Broth micro dilution method was 
used for determination of minimum inhibitory concentrations (MICs) of the extracts 
alone or in association with ciprofloxacin and Phenylalanine-Arginine β- Naphtylamide 
(PAβN) as a positive control and efflux pumps inhibitor (EPI). 
Results: MIC determination indicated that the hydro alcoholic and chloroform extracts 
from Berberis vulgaris L. root were able to inhibit the growth of all the studied bacteria 
within a concentration range of 25000 to 75000 and 1562 to 6250 µg/mL, respectively. 
Synergistic effects were noted between the extracts from Berberis vulgaris L. root 
extracts and ciprofloxacin on all tested bacteria. 
Conclusion: Berberis vulgaris L. root extracts act as an antibacterial agent and potentiate 
ciprofloxacin effects on examined pathogenic bacteria. The present investigation brings 
about primary information’s for the possible use of these extracts in association with 
fluoroquinolones. 
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Reports show this mechanism is involved 
in fluoroquinolone resistance in gram negative 
pathogenic bacteria, affecting hospitalized 
patients.
2
 The result of over expression of 
these pumps in pathogenic bacteria is the 
emergence of pathogenic strains that are 
clinically resistance to many antimicrobial 
agents such as ciprofloxacin.
3
 
Phenylalanyl-arginyl-beta-naphthylamide 
(PAßN) is a compound that has become 
known as a chemical efflux pump inhibitors 
(EPIs) 
4
. PAßN selectively inhibit the efflux 
activities of a broad range of efflux pumps 
such as MexAB-OprM, MexEF-OprN, 
MexCD-OprJ, and MexXY-OprM in  
P. aeruginosa and AcrAB-TolC in some 
species of the Enterobacteriaceae.
5
 
It is reported that the extracts from some 
medicinal plants contain compounds that 
inhibit efflux pumps of bacteria and can be 
considered as EPIs.
6
 
Berberis vulgaris L. is a medicinal herb 
that traditionally is used for its medicinal 
properties and is well known in Iran and  
most countries in the world. The different 
parts of this plant including root, leaf, bark  
and fruit have been used widely as folk 
medicine for the treatment and prevention of 
various diseases including cardiovascular, 
gastrointestinal, respiratory, skin, renal and 
infectious diseases.
7
 Previous studies have 
also been carried out on chemical composition 
of the B. vulgaris that showed the most 
important constituents of this plant are 
isoquinoline alkaloids such as Berberine.
8
 
Some reports indicated that Berberis 
species contain compounds that can enhance 
antibacterial actions of some antimicrobial 
agents.
9
 
This study was planned to search the 
antibacterial activities of the hydroalcoholic 
and chloroform extracts of Berberis  
vulgaris L. root and their synergistic effects 
with ciprofloxacin as a fluoroquinolone 
representative against some gram-negative 
pathogenic bacteria. 
METHODS 
Whole trees of Berberis vulgaris L. 
collected by local people in Khorasan 
province and transferred to department of 
botany of Shahrekord University for final 
confirmation. Dried roots were prepared in 
microbiology laboratory of veterinary college 
of the university. After grinding it was used by 
maceration method for extract preparation. 
Briefly, ethanol 85% and chloroform added to 
powdered plant roots in conical flasks and 
allowed to stand at room temperature for a 
period of 2 and 3 days for chloroform and 
ethanol solvents, respectively. Daily filtration 
and refreshing of the solvent were followed 
for the ethanol extraction, but for chloroform 
solvent one stage filtration process were used. 
The collected filtrates were evaporated by 
incubating in an incubator at 34°C, in the case 
of ethanol and in biolaminar safety hood in the 
case of chloroform solvents.
10
 All extracts 
were kept at 4°C for further investigations. 
The studied microorganisms included 
the reference strains of Pseudomonas 
aeruginosa ATCC 9027 and Acinetobacter 
baumannii, NCTC 13305 kindly deliverd by 
Dr B. Zamanzad and Dr A. Gholipour 
(Department of Microbiology, Shahrekord 
Medical school), E Coli ATCC 25922 and 
Salmonella enteritidis RTCC 2465 kindly 
delivered by Dr H. Motamedi (Department 
of Microbiology, College of Basic Sciences, 
Shahid Chamran University), were kept in 
Lauria Bertani broth (LB broth) at 4°C and 
sub cultured on appropriate agar plates 24 h 
prior to antimicrobial tests. Mueller Hinton 
broth (MHB) was used for all the 
antibacterial assays. Ciprofloxacin (cip) 
(Sigma-Aldrich) as fluoroquinolone 
representative and Phenylalanine arginine  
β-aphthylamide (PAβN) (Sigma-Aldrich) as 
microbial growth indicator and efflux pumps 
inhibitor (EPI) were used, respectively. 
After a preliminary assay by tube dilution 
method on examined drugs against four 
standard bacterial strains, the MICs for drug 
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combinations were determined following the 
method of double-serial micro dilution, 
according to guidelines of the Clinical and 
Laboratory Standards Institute.
11
 Briefly, the 
bacterial cultures were incubated aerobically 
at 37 
°
C for 18- 24 hours. The turbidity of  
the cultures adjusted to 0.5 McFarland  
(1.5×10
8
 CFU/ml) and then diluted in  
saline solution to obtain an inoculum of  
5×10
5
 CFU/well. The first well of each 96 
well micro plate rows inoculated with four 
MIC of drug/drugs followed by double 
dilution in successive wells to detect any 
possible antagonistic or synergistic 
combinations. The two last wells considered 
as positive and negative controls. 
The inoculated micro plates were 
aerobically incubated in shaking for about  
18 h at 37 
°
C. The lowest concentration that 
inhibits visible growth after incubation was 
defined as MIC. For verifying synergistic 
activity of ciprofloxacin with our extracts, 
activity of ciprofloxacin with extract 
associations was compared with that of 
ciprofloxacin plus PAßN (30 µg/ml in 
prepared stock solution) whose which 
antimicrobial activity was also tested. 
Interaction of drugs in combinations was 
calculated as the ratio of MICAntibiotic in 
combination/MICAntibiotic alone and the results 
were discussed as follows: Synergy (<0.5), 
indifferent (0.5 to 4), or antagonism (>4).
12,13
 All 
assays were performed in duplicate. 
 
RESULTS 
Hydroalcoholic and chloroform extracts 
of Berberis vulgaris L. root were examined to 
detect synergy with ciprofloxacin. The 
positive control was PAβN whose 
antimicrobial activity was also assayed on the 
examined strains (Table 1). 
 
Table 1: Minimum inhibitory concentrations (MICs), (μg/mL) of ciprofloxacin (cip), and 
Phenylalanine arginine β-aphthylamide (PAβN) in the absence and presence of Berberis vulgaris L. 
root extracts against some gram negative bacteria* 
Combination 
Bacteria 
Cip. Eth.E.  + cip. Eth.E. Ch.E.+ cip. Ch.E. PAβN PAβN+ cip. 
Ps. aeruginosa 1 0.2 3125 0.2 2340 3.75 0.125 
S. enteritidis 0.008 0.001 75000 0.002 3125 5 0.05 
E- coli 0.007 0.003 25000 0.0002 6250 6.25 0.002 
A. baumannii 0.26 0.05 75000 0.8 1562 6.25 R 
*Synergistic combinations appeared as bold numbers; *Eth.E., Ch.E.+ cip. and R Stand for hydroalcoholic extracts, 
chloroform extract, ciprofloxacin and resistant respectively. 
 
The MICs of hydroalcoholic and 
chloroform extracts and drug combinations 
against examined bacteria are appeared in 
Table 1. The chloroform extract of the 
extracts investigated generally showed a 
greater activity against examined bacteria 
(MIC, 1562 to 6250 μg/mL). By MIC 
determination, chlorophorm extract of 
Berberis vulgaris L. root showed 
synergistic activity with ciprofloxacin 
against all of the examined bacteria other 
than A. bummani (Table 1). This synergy 
showed by hydro alcoholic extract against 
all tested bacteria. 
Ebrahimi A, et al. Activities of Berberis vulgaris L. 
23 
In A. bummani, chlorophorm extract did 
not show synergy with ciprofloxacin but 
PAβN also did not reduce the MIC of 
ciprofloxacin (Table 1). 
 
DISCUSSION 
Pathogenic microorganisms have 
different ways to deal with antimicrobial 
agents such as antibiotics and indiscriminate 
uses of these compounds have led to the 
development of drug resistance. 
There is continued clinical pressure for novel 
approaches to combat antibiotic-resistances and 
identifying new antimicrobials for treating 
resistant bacterial infections. Screening plants for 
natural products with antibiotic potentiating 
effects was a successful approach.
7
 
So in the present work we examined 
Berberis vulgaris L. root hydroalcoholic and 
chloroform extracts for antibacterial activity 
and possible synergy with ciprofloxacin. 
It is reported that examined bacterial 
strains tested with a combination of Berberis 
vulgaris L. extracts, ciprofloxacin and PAβN 
all contains multidrug resistance efflux 
pumps.
3,14
 
It appears that extracts of B. vulgaris L. 
root prevent the growth of all examined 
bacterial strains in 1562 to 75000 µg/mL 
concentration range (Table 1). The lowest 
MIC value (1562 μg/mL) was obtained with 
the chloroform extract of B. vulgaris L. root 
against A. baumannii. Reports show other 
plant extracts contain compounds that 
potentiate antibiotic activity or have 
antibacterial activity.
15,16
 Also, it is reported 
that essential oil from a Corsican plant, 
Helichrysum italicum, reduced the MIC of 
chloramphenicol against Enterobacter 
aerogenes, A. baumannii and P. aeruginosa.
16
 
In terms of antibiotic potentiation with 
ciprofloxacin, the chloroform extract of  
B. vulgaris L. root showed the best activity 
against E. coli, Ps. aeroginosa and  
S. enteritidis, respectively. The best 
synertgistic activity of hydroalcoholic extract 
was recorded against S. enteritidis,  
Ps. aeroginosa and A. baumannii. These 
observations may imply that B. vulgaris L. 
root extracts contain active compounds that 
target the bacterial cell and might be powerful 
substrates of mentioned bacterial efflux 
pumps. As ciprofloxacin is a substrate of 
many bacterial efflux pumps, many reports 
indicate activity of other plant extracts that 
synergised with this agent.
1,17
 
In A. baumannii, PAβN and association 
of chloroform extract had no effect on MIC of 
ciprofloxacin. Since the presence of AcrB 
efflux pumps confers resistance to the cells 
against PAβN.18 This may imply that our 
examined strain of A. baumannii over 
expressed AcrB efflux pumps and chloroform 
extracts from B. vulgaris L. root may also 
behave such as PAβN. 
It is also worth to note that PAβN cannot 
reverse drug resistance for all drugs and has, 
for instance, no effect on efflux pump-
mediated resistance to the dye ethidium.
19
 
Berberine is an isoquinoline-type alkaloid 
with antimicrobial properties isolated from 
many kinds of Berberis species such as 
Berberis aristata, Berberis aquifolium and 
Berberis vulgaris. 
The synergistic effects of extracts of  
B. vulgaris L. with other antibiotics were 
noted on other bacteria also indicate that 
extracts of this herb can act as efflux pump 
inhibitor.
20
 
Phytochemical screening of barberry’s 
roots have also revealed the presence of 
alkaloids, flavonoids, saponin, phenolic 
contents, terpenoids and cardiac glycosides. 
Some of them have antimicrobial effects 
beside other benefits.
7
 
However, a detailed study on active 
constituents, phytochemical and toxicological 
properties of B. vulgaris L. root is suggested 
for evaluating its safety. 
Taking together, from our results we can 
suggest that using the extracts of B. vulgaris L. 
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root in associations with fluoroquinolones 
might be helpful in treating infections caused 
by examined pathogenic bacteria. 
In conclusion, extracts from B. vulgaris L. 
root were able to increase susceptibility to 
ciprofloxacin and the present investigation 
brings about primary information’s for the 
possible use of these extracts in association 
with fluoroquinolones to combat at least some 
gram negative pathogens. 
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